156 related articles for article (PubMed ID: 31244292)
1. Five-Year Overall Survival of Interval Breast Cancers is Better than Non- Interval Cancers from Korean Breast Cancer Registry.
Lee JS; Kim HA; Cho SH; Lee HB; Park MH; Jeong J; Park HK; Oh M; Yi O
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1717-1726. PubMed ID: 31244292
[TBL] [Abstract][Full Text] [Related]
2. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
4. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
Defossez G; Quillet A; Ingrand P
BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study.
Musolino A; Falcini F; Sikokis A; Boggiani D; Rimanti A; Pellegrino B; Silini EM; Campanini N; Barbieri E; Zamagni C; Degli Esposti R; Cortesi L; Bisagni G; Cavanna L; Frassoldati A; Sgargi P; Michiara M
Eur J Cancer; 2018 Jan; 88():10-20. PubMed ID: 29175735
[TBL] [Abstract][Full Text] [Related]
6. Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.
Niraula S; Biswanger N; Hu P; Lambert P; Decker K
JAMA Netw Open; 2020 Sep; 3(9):e2018179. PubMed ID: 32975573
[TBL] [Abstract][Full Text] [Related]
7. The incidence of interval cancers in the German mammography screening program: results from the population-based cancer registry in North Rhine-Westphalia.
Heidinger O; Batzler WU; Krieg V; Weigel S; Biesheuvel C; Heindel W; Hense HW
Dtsch Arztebl Int; 2012 Nov; 109(46):781-7. PubMed ID: 23264826
[TBL] [Abstract][Full Text] [Related]
8. Associations among socioeconomic status, patterns of care and outcomes in breast cancer patients in a universal health care system: Ontario's experience.
Kumachev A; Trudeau ME; Chan KK
Cancer; 2016 Mar; 122(6):893-8. PubMed ID: 26696022
[TBL] [Abstract][Full Text] [Related]
9. Long-term trends in incidence, characteristics and prognosis of screen-detected and interval cancers in women participating in the Dutch breast cancer screening programme.
Ten Velde DE; Duijm LEM; van der Sangen MJC; Schipper RJ; Tjan-Heijnen VCG; Vreuls W; Strobbe LJA; Voogd AC
Br J Cancer; 2024 May; 130(9):1561-1570. PubMed ID: 38467826
[TBL] [Abstract][Full Text] [Related]
10. Breast Density of Mammography is Correlated with Reproductive Risk Factors Regardless of Menopausal Status: A Cross-Sectional Study of the Korean National Screening Program.
Lee JS; Oh M
Asian Pac J Cancer Prev; 2020 Apr; 21(4):1011-1018. PubMed ID: 32334463
[TBL] [Abstract][Full Text] [Related]
11. Sociodemographic gradients in breast and cervical cancer screening in Korea: the Korean National Cancer Screening Survey (KNCSS) 2005-2009.
Park MJ; Park EC; Choi KS; Jun JK; Lee HY
BMC Cancer; 2011 Jun; 11():257. PubMed ID: 21682886
[TBL] [Abstract][Full Text] [Related]
12. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors and Mortality Among Women With Interval Breast Cancer vs Screen-Detected Breast Cancer.
Song H; Tran TXM; Kim S; Park B
JAMA Netw Open; 2024 May; 7(5):e2411927. PubMed ID: 38767918
[TBL] [Abstract][Full Text] [Related]
14. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognosis of breast cancer detected by mammography screening or other methods.
Lehtimäki T; Lundin M; Linder N; Sihto H; Holli K; Turpeenniemi-Hujanen T; Kataja V; Isola J; Joensuu H; Lundin J
Breast Cancer Res; 2011; 13(6):R134. PubMed ID: 22204661
[TBL] [Abstract][Full Text] [Related]
16. Survival Rates of Breast Cancer Patients Aged 40 to 49 Years according to Detection Modality in Korea: Screening Ultrasound versus Mammography.
Won SY; Park HS; Kim EK; Kim SI; Moon HJ; Yoon JH; Park VY; Park S; Kim MJ; Cho YU; Park BW
Korean J Radiol; 2021 Feb; 22(2):159-167. PubMed ID: 32901456
[TBL] [Abstract][Full Text] [Related]
17. Education Level Is a Strong Prognosticator in the Subgroup Aged More Than 50 Years Regardless of the Molecular Subtype of Breast Cancer: A Study Based on the Nationwide Korean Breast Cancer Registry Database.
Hwang KT; Noh W; Cho SH; Yu J; Park MH; Jeong J; Lee HJ; Kim J; Oh S; Kim YA;
Cancer Res Treat; 2017 Oct; 49(4):1114-1126. PubMed ID: 28161933
[TBL] [Abstract][Full Text] [Related]
18. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
Roder D; Webster F; Zorbas H; Sinclair S
Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
[TBL] [Abstract][Full Text] [Related]
19. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
20. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening.
Tabár L; Dean PB; Chen TH; Yen AM; Chen SL; Fann JC; Chiu SY; Ku MM; Wu WY; Hsu CY; Chen YC; Beckmann K; Smith RA; Duffy SW
Cancer; 2019 Feb; 125(4):515-523. PubMed ID: 30411328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
